In conclusion, our present study confirmed that miR-34a overexpression could suppress NSCLC progression by upregulating PTEN and YY1 expression while downregulating CDK6 expression, and indicated that PI3K/AKT signaling might be involved in miR-34a-regulatory mechanisms. The gene discussed is AKT1; the disease is non-small cell lung carcinoma.